All In Biotech

Free tool

FAERS Monitor: Geodon

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020825 or its brand name (Geodon, Ziprasidone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

17,662

Serious

12,204

69% of reports

Hospitalization

4,288

Death reported

1,238

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,438
  • weight increased1,185
  • diabetes mellitus1,004
  • anxiety883
  • type 2 diabetes mellitus859
  • insomnia806
  • depression792
  • somnolence750
  • fatigue727
  • tardive dyskinesia707
  • tremor699
  • nausea682
  • dizziness594
  • feeling abnormal591
  • suicidal ideation577

Reports by year received

View as table
YearReports
2004559
2005664
2006718
2007860
2008438
20091,102
20102,777
20111,613
20121,060
2013734
2014612
2015833
2016867
2017711
2018643
2019660
2020619
2021517
2022474
2023364
2024290
2025304
2026243

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,497 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
type 2 diabetes mellitusSignal85931.229.224,442
tardive dyskinesiaSignal70730.628.419,723
diabetes mellitusSignal1,00415.914.913,849
suicidal ideationSignal5777.57.03,264
weight increasedSignal1,1856.36.05,341
tremorSignal6995.04.72,263
somnolenceSignal7504.44.12,013
depressionSignal7924.23.91,909
anxietySignal8833.73.51,758
insomniaSignal8063.63.41,534
feeling abnormalSignal5912.92.7762
dizziness5941.41.375
drug ineffective1,4381.31.2106
fatigue7271.11.08
nausea6821.01.00

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.